Detection of vancomycin resistant Staphylococcus aureus: A comparative study of three different phenotypic screening methods

Indian Journal of Medical Microbiology

Volumn 23, Issue 1, 2005, Pages 52-55

  Bhateja, P ^a   Mathur, T ^a   Pandya, M ^a   Fatma, T ^b   Rattan, Ashok ^a  

^a RANBAXY RESEARCH LABORATORIES   (India)

^b JAMIA MILLIA ISLAMIA CENTRAL UNIVERSITY   (India)

Author keywords

Glycopeptide; MIC; Screening; VISA; VRSA

Indexed keywords

VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; INTERMETHOD COMPARISON; MICROBIOLOGICAL EXAMINATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; PROFESSIONAL STANDARD; QUALITY CONTROL; SCREENING TEST; STAPHYLOCOCCUS AUREUS; STRAIN IDENTIFICATION;

EID: 14844297361     PISSN: 02550857     EISSN: None     Source Type: Journal    
DOI: 10.4103/0255-0857.13875     Document Type: Article

References (12)

1. Wootton M, Howe RA, Hillman R, Walsh TR, Bennett PM, MacGowan AP. A modified population analysis (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob chemother 2001;47:399-403.
2. Tenover CF, Lancaster MV, Hill CB, Steward CD, Stocker SA, Hancock GA, O'hara CM, Clark NC, Hiramatshu K. Characterization of Staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998;34(4): 1020-1027.
3. Fridkin SK. Vancomycin intermediate and resistant Staphylococcus aureus: What the infectious diseases specialist needs to know. Clin Infect Dis 2001;32:108-115.
4. Tenover CF, Biddle JW, Lancaster MV. Increasing resistance to vancomycin and other glycopeptides in Staphylococcus aureus. Emerging Infect Dis 2001;7(2):327-332.
5. Huber SK, Mohammed JM, Fridkin SK, Gaynes RP, McGowan JE, Tenover FC. Glycopeptide intermediate Staphylococcus aureus: Evaluation of a novel screening methods and results of a survey of selected U.S hospitals. J Clin Microbiol 1999; 37(11): 3590-3593.
6. Srinivasan A, Dick JD, Perl TM. Vancomycin resistance in Staphylococci. Clin Microbiol Rev 2002;15(3):430-438.
7. Hiramatshu K. Vancomycin resistance in staphylococci. Drugs Resistance Updates 1998;1: 135-150.
8. Wayne PA. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 5th edition Approved standard M7-A5. 2000.
9. Hiramatshu K, Aritaka N, Hanaki H, Kawasaki S, Hosoda Y, Hori S. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350:1670-1673.
10. Daum RS, Gupta S, Sabbagh R, Milewski WM. Characterization of Staphylococcus aureus isolates with decreased susceptibility to vancomycin and teicoplanin; Isolation and purification of constitutively produced proteins associated with decreased susceptibility. J Infect Dis 1992;166:1066-1072.
11. Howe RA, Wootton M, Walsh TR, Bennett PM, Macgowan AP. Expression and detection of heterovancomycin resistance in Staphylococcus aureus. J Antimicrob Chemother 1999; 44:675-678.
12. Bierbaum G, Fuchs K, Lenz W, Szekat C, Sahl HG. Presence of Staphylococcus aureus with reduced susceptibility to vancomycin in Germany. Eur J clin Microbiol Infect Dis 1999;18:691-696.